Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Pont, Margot J  [Clear All Filters]
Journal Article
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, et al. γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023;24(7):811-822.
van der Lee DI, Pont MJ, Falkenburg JHFrederik, Griffioen M. The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants. PLoS One. 2016;11(9):e0162808.
Wilkens AB, Fulton E, Pont MJ, Cole GO, Leung I, Stull SM, Hart MR, Bernstein ID, Furlan SN, Riddell SR. NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness. Blood. 2022.
Pont MJ, Hobo W, Honders MW, van Luxemburg-Heijs SAP, Kester MGD, van Oeveren-Rietdijk AM, Schaap N, de Boer HC, van Bergen CAM, Dolstra H, et al. LB-ARHGDIB-1R as novel minor histocompatibility antigen for therapeutic application. Haematologica. 2015.
Hombrink P, Hassan C, Kester MGD, Jahn L, Pont MJ, de Ru AH, van Bergen CAM, Griffioen M, Falkenburg JHFrederik, van Veelen PA, et al. Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte derived HLA-ligandome using a reverse immunology approach. Clin Cancer Res. 2015.